“Bimekizumab Long-Term On-Treatment Remission and Associated Sustained Improvements in Quality of Life in Moderate to Severe Plaque Psoriasis Across Five Phase 3/3b Trials” (2026) SKIN The Journal of Cutaneous Medicine, 10(3), p. s772. doi:10.25251/pkdcct35.